Just a DD share of info/rumors/opinion to those visiting this board:
I cannot see how this will go down much further. BUT ...IMO ...anything below par value (.001) is a buy. As I write PMBS is at .0007. My personal hope is to get a final mily at .0006 but that seems more and more dim as we are obviously getting closer and closer to the relaunch.
I am a long and feel anyone who wants to make money should imo, invest now. LipiG is being reformulated/repackaged and the (guessing) Insomnia, headache, and Migraine products are about to be on the shelves...maybe not all at once, I dunno...maybe phased in over a period of time.
We have all the biggie not-chart fundamental bullish signposts here: insider buying of 400,000,000 shares (instead of salary), pps below par value with looming relaunch, great products and product pipeline, reporting co., huge sector support, a product that is proven effective, way oversold share price, OS (outstanding shares) structure still very good, I think you get the drift...
Warren Buffet said buy the company when it is on the operating table
… on when to buy
“The best thing that happens to us is when a great company gets into temporary trouble…We want to buy them when they’re on the operating table.”
Source: Businessweek, 1999
Well, this company has been on the operating table and is now getting off that table with all vital organs having being transplanted.
IMHO pps will then double several times over from where it was (.0006) last week or so. Do your own DD and make your own informed decision. Hope I've whet your own appetite to do your own research.
GLTA and LONG PMBS
I cannot see how this will go down much further. BUT ...IMO ...anything below par value (.001) is a buy. As I write PMBS is at .0007. My personal hope is to get a final mily at .0006 but that seems more and more dim as we are obviously getting closer and closer to the relaunch.
I am a long and feel anyone who wants to make money should imo, invest now. LipiG is being reformulated/repackaged and the (guessing) Insomnia, headache, and Migraine products are about to be on the shelves...maybe not all at once, I dunno...maybe phased in over a period of time.
We have all the biggie not-chart fundamental bullish signposts here: insider buying of 400,000,000 shares (instead of salary), pps below par value with looming relaunch, great products and product pipeline, reporting co., huge sector support, a product that is proven effective, way oversold share price, OS (outstanding shares) structure still very good, I think you get the drift...
Warren Buffet said buy the company when it is on the operating table
… on when to buy
“The best thing that happens to us is when a great company gets into temporary trouble…We want to buy them when they’re on the operating table.”
Source: Businessweek, 1999
Well, this company has been on the operating table and is now getting off that table with all vital organs having being transplanted.
IMHO pps will then double several times over from where it was (.0006) last week or so. Do your own DD and make your own informed decision. Hope I've whet your own appetite to do your own research.
GLTA and LONG PMBS
